Vaccine Adjuvants Market by Application and Geography - Forecast and Analysis 2020-2024

Vaccine Adjuvants Market by Application and Geography - Forecast and Analysis 2020-2024

Global Vaccine Adjuvants Market: About this market

Technavio’s vaccine adjuvants market analysis considers sales from infectious diseases, cancer, and other diseases. Our study also finds the sales of vaccine adjuvants in Asia, Europe, North America, and ROW. In 2019, the infectious diseases segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as R&D activities for the formulation of novel adjuvants to prevent the spread of infectious diseases will play a significant role in the infectious diseases segment to maintain its market position. Also, our global vaccine adjuvants market report looks at factors such as increasing use of adjuvants in vaccines, growing support of government in R&D, and initiatives to increase awareness of immunization programs and access to vaccines. However, side effects of adjuvants, inherent limitations of adjuvants, and safety concerns associated with vaccine adjuvants may hamper the growth of the vaccine adjuvants industry over the forecast period.

Global Vaccine Adjuvants Market: Overview

Initiatives to increase awareness of immunization programs and access to vaccines

Infants and children are prone to deadly diseases like hepatitis B, measles, and tetanus, which can cause serious harm. The lack of immunization awareness can lead to the propagation of such deadly diseases when simple measures could eradicate them completely. Therefore, raising awareness about immunization programs and increasing the access to vaccines is important. Awareness campaigns such as the World Immunization Week are celebrated at the end of April every year to raise awareness about how immunization and vaccination can fight against a host of diseases. Such initiatives will lead to the expansion of the global vaccine adjuvants market at a CAGR of almost 11% during the forecast period.

Development of nanoparticle adjuvants

Nanotechnology offers a multifunctional stage for the integration of desired adjuvant activities. Due to the high efficacy of vaccine adjuvants in potentiating a strong immune response in individuals, vendors are focusing on developing new-generation adjuvants to create a more potent antigen-specific response. Nanoparticles for antigen delivery can provide high bioavailability as well as constant and controlled-release profiles. Moreover, the immune-regulating activity of nanoparticles can further promote and shape cellular and humoral immune responses. Therefore, the combination of delivery functions and immunomodulatory effects of nanoparticles as adjuvants is expected to benefit the immune outcomes of vaccination largely. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global vaccine adjuvants market during the forecast period 2020-2024, click here.

Competitive Landscape

With the presence of a few major players, the global vaccine adjuvants market is highly concentrated. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of few leading vaccine adjuvants manufacturers, that include Agenus Inc., Avanti Polar Lipids Inc., Croda International Plc, CSL Ltd., GlaxoSmithKline Plc, InvivoGen, Merck KGaA, OZ Biosciences SAS, SEPPIC SA, and Vaxine Pty Ltd..

Also, the vaccine adjuvants market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.


  • Executive summary
  • Scope of the report
    • Preface
      • Table Vendor key offerings
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
    • Parent market
      • Table Global pharmaceuticals market
      • Table Segments of global pharmaceuticals market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2019
      • Table Market size 2019
    • Market size and forecast 2019-2024
      • Table Global market: Size and forecast 2019-2024 ($ millions)
      • Table Global market: Year-over-year growth 2020-2024 (%)
    • Market Outlook
  • Five forces analysis
    • Table Five forces analysis 2019
    • Table Five forces analysis 2024
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2019
  • Market segmentation by application
    • Table Application - Market share 2019-2024 (%)
    • Comparison by application
      • Table Comparison by application
    • Infectious diseases - Market size and forecast 2019-2024
      • Table Infectious diseases - Market size and forecast 2019-2024 ($ millions)
      • Table Infectious diseases - Year-over-year growth 2020-2024 (%)
    • Cancer - Market size and forecast 2019-2024
      • Table Cancer - Market size and forecast 2019-2024 ($ millions)
      • Table Cancer - Year-over-year growth 2020-2024 (%)
    • Other diseases - Market size and forecast 2019-2024
      • Table Other diseases - Market size and forecast 2019-2024 ($ millions)
      • Table Other diseases - Year-over-year growth 2020-2024 (%)
    • Market opportunity by application
      • Table Market opportunity by application
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2019-2024 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2019-2024
      • Table North America - Market size and forecast 2019-2024 ($ millions)
      • Table North America - Year-over-year growth 2020-2024 (%)
      • Table Top 3 countries in North America
    • Europe - Market size and forecast 2019-2024
      • Table Europe - Market size and forecast 2019-2024 ($ millions)
      • Table Europe - Year-over-year growth 2020-2024 (%)
      • Table Top 3 countries in Europe
    • Asia - Market size and forecast 2019-2024
      • Table Asia - Market size and forecast 2019-2024 ($ millions)
      • Table Asia - Year-over-year growth 2020-2024 (%)
      • Table Top 3 countries in Asia
    • ROW - Market size and forecast 2019-2024
      • Table ROW - Market size and forecast 2019-2024 ($ millions)
      • Table ROW - Year-over-year growth 2020-2024 (%)
      • Table Top 3 countries in ROW
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Impact of drivers and challenges
  • Market trends
    • Increase in R&D of novel vaccine adjuvants
    • Development of nanoparticle adjuvants
    • Rising number of collaborations
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Agenus Inc.
      • Table Agenus Inc. - Vendor overview
      • Table Agenus Inc. - Business segments
      • Table Agenus Inc. - Organizational developments
      • Table Agenus Inc. - Geographic focus
      • Table Agenus Inc. - Key offerings
      • Table Agenus Inc. - Key customers
    • Avanti Polar Lipids Inc.
      • Table Avanti Polar Lipids Inc. - Vendor overview
      • Table Avanti Polar Lipids Inc. - Business segments
      • Table Avanti Polar Lipids Inc. - Organizational developments
      • Table Avanti Polar Lipids Inc. - Key offerings
      • Table Avanti Polar Lipids Inc. - Key customers
    • Croda International Plc
      • Table Croda International Plc - Vendor overview
      • Table Croda International Plc - Business segments
      • Table Croda International Plc - Organizational developments
      • Table Croda International Plc - Geographic focus
      • Table Croda International Plc - Segment focus
      • Table Croda International Plc - Key offerings
      • Table Croda International Plc - Key customers
    • CSL Ltd.
      • Table CSL Ltd. - Vendor overview
      • Table CSL Ltd. - Business segments
      • Table CSL Ltd. - Organizational developments
      • Table CSL Ltd. - Geographic focus
      • Table CSL Ltd. - Segment focus
      • Table CSL Ltd. - Key offerings
      • Table CSL Ltd. - Key customers
    • GlaxoSmithKline Plc
      • Table GlaxoSmithKline Plc - Vendor overview
      • Table GlaxoSmithKline Plc - Business segments
      • Table GlaxoSmithKline Plc - Organizational developments
      • Table GlaxoSmithKline Plc - Geographic focus
      • Table GlaxoSmithKline Plc - Segment focus
      • Table GlaxoSmithKline Plc - Key offerings
      • Table GlaxoSmithKline Plc - Key customers
    • InvivoGen
      • Table InvivoGen - Vendor overview
      • Table InvivoGen - Product segments
      • Table InvivoGen - Key offerings
      • Table InvivoGen - Key customers
    • Merck KGaA
      • Table Merck KGaA - Vendor overview
      • Table Merck KGaA - Business segments
      • Table Merck KGaA - Organizational developments
      • Table Merck KGaA - Geographic focus
      • Table Merck KGaA - Segment focus
      • Table Merck KGaA - Key offerings
      • Table Merck KGaA - Key customers
    • OZ Biosciences SAS
      • Table OZ Biosciences SAS - Vendor overview
      • Table OZ Biosciences SAS - Product segments
      • Table OZ Biosciences SAS - Key offerings
      • Table OZ Biosciences SAS - Key customers
    • SEPPIC SA
      • Table SEPPIC SA - Vendor overview
      • Table SEPPIC SA - Product segments
      • Table SEPPIC SA - Organizational developments
      • Table SEPPIC SA - Key offerings
      • Table SEPPIC SA - Key customers
    • Vaxine Pty Ltd.
      • Table Vaxine Pty Ltd. - Vendor overview
      • Table Vaxine Pty Ltd. - Business segments
      • Table Vaxine Pty Ltd. - Key offerings
      • Table Vaxine Pty Ltd. - Key customers
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
    • Definition of market positioning of vendors
      • Table Definition of market positioning of vendors
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook